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The diagnosis of idiopathic pulmonary fibrosis (IPF) currently requires an integrated clini-
caleradiologicalepathological approach in which the histology plays a different role from in
the past. The first reason for this change is that non-invasive diagnostic procedures, particu-
larly pulmonary function tests and high resolution computed tomography, have become
increasingly competitive with biopsy in providing prognostic information. The other reason is
a better appreciation of the limitations of histology: sampling error and interobserver varia-
tion. In this review we analyze the reasons for this change of perspective, provide an update
on the practical role of histology in the diagnosis of IPF and discuss some of its complications.
ª 2010 Elsevier Ltd. All rights reserved.Introduction
In the last few years the diagnosis of idiopathic pulmonary
fibrosis (IPF) has gradually shifted from a situation in which
biopsy was the single gold standard to a more complex
paradigm in which the histology is part of a dynamic
multidisciplinary approach integrating the clinical, radio-
logical and pathological data.1e4n; CVD, collagen vascular disease
ography; ILD, interstitial lung d
titial pneumonia; OP, organizing p
2 295917; fax: þ39 522 296054.
smn.re.it (A. Cavazza).
0 Elsevier Ltd. All rights reservedThe reasons for this profound change are twofold. First,
the non-invasive diagnostic procedures, particularly
pulmonary function tests5e9 and high resolution computed
tomography (HRCT),10,11 became increasingly competitive
with biopsy in providing prognostic information. Nowadays
they are a sufficient surrogate of biopsy in a significant
proportion of patients, and when biopsy remains necessary
they integrate with histological results. For example,; DAD, diffuse alveolar damage; HP, hypersensitivity pneumonitis;
isease; IPF, idiopathic pulmonary fibrosis; LCH, Langerhans’ cell
neumonia; UIP, usual interstitial pneumonia.
.
S12 A. Cavazza et al.when HRCT appearance is typical of usual interstitial
pneumonia (UIP) a non-invasive (clinico-radiological)
diagnosis of IPF is almost always accurate.12 As a corollary,
biopsy is required only when the HRCT scan and/or the
clinical features are not typical of UIP, a situation occur-
ring in <50% of patients with IPF. In this scenario the
correct classification of the disease is based on histology,
and the histological distinction between UIP and non-
specific interstitial pneumonia (NSIP) provides important
prognostic information.13 In other words, when clinico-
radiological data are inconclusive and biopsy is deemed
necessary, histology generally remains the most important
piece of the diagnostic puzzle. However, HRCT maintains
a role in determining the most appropriate site of biopsy,
and the prognosis is further refined when histological data
are integrated with HRCT14 and clinico-functional
parameters.15
Together with the growing importance of non-invasive
procedures, the other reason for the change in the role of
histology in IPF is a better appreciation of its limitations.
The first limit of histology is sampling errors e any disease
in the lung is heterogeneous, and a biopsy in different
areas may provide different results. For example, in IPF
an optimal biopsy will demonstrate UIP, but a suboptimal
biopsy may show only non-diagnostic honeycomb, areas of
NSIP or a background of smoking-related changes. In
particular, areas histologically indistinguishable from NSIP
commonly occur in UIP16: they are generally focal, but
sometimes they are extensive. If the wrong area is
sampled a histological diagnosis of NSIP can be misleading
because the prognosis will be dictated by the non-
sampled UIP.17,18
The problems related to sampling can be reduced by
obtaining an optimal biopsy (Table 1) and correlating the
histology with the clinical and radiological data: if the
histology does not explain the clinico-radiological scenario,
the possibility that the relevant disease has not been
sampled should be considered. It is important to note that
the pathologist has to maintain an open mind because the
histological interpretation can be modified by clinical and
radiological data.
The second limit of histology in interstitial lung disease
(ILD) is interobserver variation. Several recent studies
evaluating this issue showed variable agreement not only
among pathologists but also among clinicians and radiol-
ogists.19e23 In particular, Flaherty et al.23 reached the
following conclusions: 1) interobserver agreement is better
among experts than non-experts, but is not perfect even
among experts; 2) agreement between experts and non-
experts is variable, but in general is quite low e the field in
which experts and non-experts most frequently disagree isTable 1 Characteristics of an optimal biopsy.
Surgical biopsy
Accurate selection of the site of biopsy (based on
computed tomography)
Artefacts as few as possible
Multiple biopsies from at least two different areas;
biopsies deep and large enough (>3 cm)the differential diagnosis of IPF, NSIP, collagen vascular
disease (CVD) and chronic hypersensitivity pneumonitis
(HP), with non-experts being more likely to assign a diag-
nosis of IPF; and 3) an iterative diagnostic approach
improves the interobserver agreement.
It is likely that continued education and increased
interaction between experts and non-experts could reduce
interobserver variation23; however both interobserver
variation and sampling errors are only partially avoidable
because they are intrinsic to histology. Not surprisingly,
pathologists have to deal with them not only in ILD but also
in many other fields.24e33 As emphasized by Wells, “.
histopathologic appearances may be intermediate between
two entities in a significant proportion of cases, and
observer variation may be an appropriate and accurate
reflection of this fact”.2
In summary, in IPF (and in ILD in general) the growing
importance of non-invasive procedures and the better
perception of the limits of histology (particularly sampling
errors and observer variation) have gradually transformed
histology from the sole gold standard to a piece of the
diagnostic puzzle, a much more complex and stimulating
situation for the pathologist because it requires not only
correct evaluation of the histology but also its correct
interpretation in light of the clinical and radiological
information. In the following pages we will examine the
practical role of histology in IPF, focusing on the main
scenarios in which the pathologist can be involved.Histological diagnosis of UIP
The histological features of UIP are beautifully described in
recent papers.34e36 The diagnostic keys are: 1) a patchwork
appearance resulting from alternating areas of scarred and
normal lung; 2) architectural distortion; and 3) fibroblastic
foci.
At low magnification (Fig. 1A), the disease is non-
uniform because of an irregular juxtaposition of scarred
and normal or nearly normal lung (spatial heterogeneity).
The scarred areas frequently prevail in the subpleural/
paraseptal regions (Fig. 1B), with an abrupt transition with
normal lung (patchwork pattern).16,34 The architecture is
distorted, with honeycomb and thick scars obscuring the
alveolar framework.
Honeycomb (Fig. 1C), which can be absent in early
cases, consists of enlarged airspaces lined by bronchiolar
epithelium and frequently filled by mucous and inflamma-
tory cells, mostly neutrophils and macrophages. The back-
ground architecture is distorted, which is the key to
differentiating honeycomb from the enlarged airspacesTransbronchial biopsy
Accurate selection of the site of biopsy (based
on computed tomography)
Artefacts as few as possible
Biopsies adequate for dimension and number
(at least 4e6 fragments, with alveolar
parenchyma present in the majority)
Figure 1 Histology of usual interstitial pneumonia. A) At low magnification the diagnostic key is the abrupt alternating of scarred
and normal lung (patchwork pattern: scar-normal-scar-normal). In the scarred areas the alveolar architecture is obliterated
(haematoxylineeosin  20). B) The fibrosis frequently prevails at the periphery of the lobule in the subpleuraleparaseptal regions
(arrows), with relative sparing of the centrolobule. This is a useful diagnostic clue, particularly in early cases like here
(haematoxylineeosin  20). C) Honeycomb consists of enlarged airspaces lined by bronchiolar epithelium, frequently filled by
mucus and surrounded by dense scars. Note the architectural distortion and the abrupt transition with residual normal lung seen in
the right upper corner (haematoxylineeosin  20). D) A fibroblastic focus consisting of a dome-shaped proliferation of myofi-
broblasts immersed in a myxoid matrix. Fibroblastic foci can be covered by bronchiolar epithelium, as here, or by hyperplasic
pneumocytes (haematoxylineeosin  100).
Histology in idiopathic pulmonary fibrosis S13that can be seen in fibrosing NSIP (see below) and from
peribronchiolar metaplasia, a frequent incidental finding in
many conditions, including UIP.37 Smooth-muscle hyper-
plasia is frequently seen in scarred lung and can be prom-
inent in some cases.
Fibroblastic foci (Fig. 1D) are present in the background
of scarring, frequently at the interface with normal lung,
and consist of small, dome-shaped interstitial collections of
myofibroblasts within myxoid stroma, covered by hyper-
plastic pneumocytes or bronchiolar cells. Generally they
are easily seen, even at low magnification, because of their
pale appearance, which contrasts with the pink colour of
scars. Being the site of ongoing injury fibroblastic foci
indicate active disease, whereas fibrotic scars and honey-
comb indicate an injury occurring in the distant past
(temporal heterogeneity). In patients with IPF extensive
fibroblastic foci have been associated with a particularly
poor prognosis in some studies, but not all.38
Inflammation is frequently present in UIP, including
small areas simulating eosinophilic pneumonia39 andoccasional incidental granulomas. A cellular infiltrate
including lymphoid follicles can be quite prominent in
honeycomb, but outside these areas inflammation is
generally minimal and overshadowed by fibrosis.The role of special stains
Histochemical and immunohistochemical stains are invalu-
able in some specific settings, in particular Ziehl-Neelsen,
Grocott, Gram and several immunohistochemical markers if
an overinfection is a consideration; elastic stains to eval-
uate vessels in pulmonary hypertension; iron stains to
search for asbestos bodies; and p63 or high-molecular-
weight cytokeratins to differentiate adenocarcinoma from
peribronchiolar metaplasia in difficult cases.40 However,
none of these markers has proved useful in the diagnosis of
uncomplicated UIP. Trichrome stains fibrosis, but fibrosis is
generally obvious in sections routinely stained with
haematoxylineeosin.
S14 A. Cavazza et al.Much more promising are immunohistochemical markers,
which may be useful in difficult cases to highlight subtle
modifications that may be overlooked when stained with
haematoxylineeosin.41 We think it is worth investigating if
this level of sensitivity is practically relevant, i.e. if diag-
nosing IPF with immunomarkers has a superior prognostic
impact to using haematoxylineeosin. Until these studies are
performed, in our opinion, the pathological diagnosis of UIP
should be based on the careful evaluation of high-quality
routinely stained slides. In our practice we use special stains
when the artefacts are so heavy as to preclude a detailed
evaluation of routine sections.
The role of transbronchial biopsy
Occasionally, transbronchial (but also transthoracic) biop-
sies performed in patients with IPF show histological
features of UIP (Fig. 2). In the only article addressing this
topic, the diagnostic sensitivity of transbronchial biopsies
in UIP was about 30%.42 However, this was a retrospective
and unblinded study in which all the patients were knownFigure 2 Histological featuresofusual interstitial pneumonia in sm
with a clinico-radiological diagnosis of idiopathic pulmonary fibrosis (
with a dense scar side-by-side with normal lung (haematoxylineeos
D) A transthoracic biopsy in an elderly male with a clinico-radiologic
formed for a peripheral nodule, which was not sampled (haematoxyl
parenchyma (haematoxylineeosin 20). F) A fibroblastic focus (hae
pneumonia, the diagnostic specificity of these findings is not proved.to have UIP, and further prospective studies in which
a variety of fibrotic ILD are blindly evaluated are clearly
needed before transbronchial biopsy can be recommended
in the workup of patients with suspected IPF. In our
opinion, as also emphasized in the editorial accompanying
the paper of Berbescu et al.,43 until such studies are
performed the histological diagnosis of UIP requires
a surgical biopsy.
We also think that the claimed role of transbronchial
biopsy in suggesting an alternative diagnosis44 is question-
able in the subset of well-studied patients with idiopathic
fibrosing ILD and an HRCT atypical for UIP, the setting in
which a biopsy is required for the diagnosis. For example,
occasional granulomas can be found in IPF as an incidental
finding, and their presence is not per se diagnostic of HP or
sarcoidosis if the clinico-radiological scenario does not
support these possibilities. In practice, if the fibrosing ILD is
considered idiopathic after an accurate clinical workup,
very rarely will the results of a transbronchial biopsy be
strong enough to be diagnostic and spare the patient
a subsequent surgical biopsy.all biopsies. A)A generous transbronchialbiopsy inanelderlymale
haematoxylineeosin 20). B) A small area of patchwork pattern,
in  100). C) A fibroblastic focus (haematoxylineeosin  200).
al diagnosis of IPF, showing a scarred lung. The biopsy was per-
ineeosin 20). E) Abrupt transition between scarred and normal
matoxylineeosin 200). Although suggestive of usual interstitial
Figure 3 Histology of fibrosing non-specific interstitial pneumonia (NSIP). A) Uniform interstitial fibrosis with preservation of the
alveolar architecture. At low magnification the absence of patchwork and architectural distortion are the keys to differentiating
NSIP from usual interstitial pneumonia (compare with Fig. 1A). Note the absence of honeycomb and fibroblastic foci (the fibrosis is
all of the same age) (haematoxylineeosin  20). B) Also in areas in which fibrosis is more marked, the alveolar framework is still
recognizable (haematoxylineeosin  20). C) Sometimes in NSIP the fibrosis is looser, a feature rarely seen in usual interstitial
pneumonia (haematoxylineeosin  40). D) Enlarged airspaces surrounded by interstitial fibrosis and lined with bronchiolar or
alveolar epithelium. These enlarged airspaces are quite frequent in fibrosing NSIP and differ from honeycomb in the finer character
of the fibrosis, which respects the alveolar architecture (compare with Fig. 1C) (haematoxylineeosin  40).
Histology in idiopathic pulmonary fibrosis S15Differential diagnosis of UIP and fibrosing NSIP
A pattern of NSIP can be found at histology in several
clinical settings, particularly CVD, HP and drug reactions, or
it can be idiopathic. In two recent papers13,45 4% and 10% of
patients initially considered idiopathic developed a CVD
during the follow-up, and in another study46 88% of idio-
pathic cases met the definition of undifferentiated
connective tissue disease. In practice, a histologicalTable 2 Contrasting histological features of usual interstitial
monia (NSIP).
UIP
Character of the fibrosis Non-uniform (spatial he
Architecture Distorted
Honeycomb Frequently present
Fibroblastic foci Present (temporal hetediagnosis of NSIP should prompt the clinician to carefully
exclude a secondary form. By contrast with IPF, which
typically occurs in old smokers, idiopathic NSIP prevails in
middle-aged patients who have never smoked.13 Although it
is not clear how much weight can be attached to this
clinical difference in a single case,47,48 in practice the
pathologist has to be particularly careful before making
a diagnosis of UIP in a relatively young patient who never





rogeneity) Absent or very few
Table 3 Histological features which, when present in usual interstitial pneumonia, suggest diseases different from idiopathic
pulmonary fibrosis (IPF).
Histological feature Consider
Cellular lymphoplasmacytic infiltrate and/or cellular
bronchiolitis and/or lymphoid follicles
Collagen vascular disease, chronic hypersensitivity
pneumonitis
Peribronchiolar fibrosis (sometimes bridging to the periphery of
the lobule)
Chronic hypersensitivity pneumonitis, pneumoconiosis
Pleuritis Collagen vascular disease
Granulomas Depending on the morphology and localization of
granulomas64,65: infection (particularly atypical
mycobacterial infection secondary to traction
bronchiectasis), chronic hypersensitivity pneumonitis,
chronic sarcoidosis, IPF arising in a background of
incidental sarcoidosis, incidental finding in IPF
Abundant coarse iron pigment Asbestosis (do iron stains on several slides to search for
asbestos bodies, which can be few), chronic
haemorrhage (consider the possibility of ANCA-
associated fibrosis66)
Foamy macrophages with eosinophils Drug reaction (focal areas resembling eosinophilic
pneumonia are an unusual incidental finding in IPF39)
S16 A. Cavazza et al.Microscopically, NSIP is characterized by thickening of the
interstitium by inflammatory cells (lymphocytes and plasma
cells) in the cellular variant, or by fibrosis in the fibrosing
variant.13,49 Mixed forms occur, and are included in the
fibrosing group.13 Whereas the distinction between UIP and
cellular NSIP is straightforward, in a minority of patients
the differential diagnosis between UIP and fibrosing NSIPFigure 4 Examples of secondary usual interstitial pneumonia. A)
arthritis (case courtesy of Prof. T.V. Colby, Scottsdale, USA). Note th
the clue to suspecting an underlying collagen vascular disease (ha
farmer. The centrolobular involvement with fibrosis bridging to th
uloma (insert), are characteristic of chronic hypersensitivity pneum(although clinically relevant)13,50 is difficult, with occa-
sional cases in which a firm distinction is impossible. This
generally results from poor sampling, although occasional
cases are difficult to classify because they lie in the grey
zone between the two entities. In these situations an open
discussion between clinician, radiologist and pathologist
can be particularly fruitful, but when the case remainsSurgical lung biopsy in a middle-aged woman with rheumatoid
e numerous lymphoid follicles with germinal centres, which are
ematoxylineeosin  20). B) Surgical lung biopsy in an elderly
e periphery of the lobule, and the small peribronchiolar gran-
onitis (haematoxylineeosin  20).
Figure 5 Histology of smoking-related fibrosis and chronic Langerhans’ cell histiocytosis (LCH). A) Dense ropy collagen typical of
smoking-related fibrosis (haematoxylineeosin  40). B) Smoking-related fibrosis frequently surrounds enlarged airspaces, both in
subpleural and centrolobular regions. In the centre-right of the picture note the intra-alveolar accumulation of pigmented
macrophages (respiratory bronchiolitis) (haematoxylineeosin  20). C) Stellate peribronchiolar scar typical of chronic LCH, causing
traction emphysema. This kind of fibrosis, totally different from usual interstitial pneumonia, is diagnostic of chronic LCH even in
the absence of residual Langerhans’ cells (haematoxylineeosin  20). D) Pigmented macrophages entrapped within fibrosis.
Although not entirely diagnostic, this feature is characteristic of LCH (haematoxylineeosin  200).
Figure 6 Surgical lung biopsy showing usual interstitial
pneumonia with numerous fibroblastic foci and organizing
pneumonia. A case like this lies somewhere on the spectrum
between stable idiopathic pulmonary fibrosis and acute exac-
erbation. This biopsy was performed for a recent worsening of
symptoms, but the patient did not satisfy the clinical criteria
for acute exacerbation (haematoxylineeosin  40).
Histology in idiopathic pulmonary fibrosis S17unsolved it may be advisable to refer the patient (or the
slides) to a centre with expertise in ILD.23 The histology of
fibrosing NSIP is shown in Fig. 3, and the contrasting
features with UIP are presented in Table 2.
Differential diagnosis of IPF and secondary UIP
In addition to IPF other diseases that may present with
a UIP pattern include CVD,51,52 chronic HP,53e59 asbes-
tosis,60 drug reaction61 and familial ILD.62,63 In some cases
these diseases are perfect histological mimics of IPF and
the distinction is based exclusively on clinical grounds. In
other cases there are histological features (sometimes
subtle) that may suggest the possibility of one of these
diseases (Table 3, Fig. 4). Importantly, none of these
features is diagnostic per se and the final diagnosis should
always rest on the careful correlation of the histology with
the clinical data. Nonetheless, it is important for the
pathologist to suggest (when it is possible) a secondary UIP
rather than IPF because the distinction may have prognostic
implications in some settings, although it is probably less
Figure 7 Adenocarcinoma arising in usual interstitial pneumonia and its main simulators. A) Surgical lung biopsy showing usual
interstitial pneumonia partially obscuring a complex epithelial proliferation (arrow) (haematoxylineeosin  20). B) At higher
magnification the epithelial proliferation is composed of columnar cells with crowded nuclei and uniform moderate atypia: their
monomorphism and the lack of cilia are the keys to recognizing this bland proliferation as adenocarcinoma
(haematoxylineeosin  400). C) An immunohistochemical stain for p63 demonstrating the lack of basal cells in adenocarcinoma; by
contrast, p63-positive basal cells are present in the benign bronchiole seen in the upper part of the picture
(peroxidaseeantiperoxidase  100). D) A surgical lung biopsy showing fibrosing non-specific interstitial pneumonia, with a marked
peribronchiolar metaplasia, simulating an adenocarcinoma in its complexity (haematoxylineeosin  20). E) At higher magnification
the proliferating cells are bland and focally show long cilia (arrow). Long cilia are not present in adenocarcinoma of the lung and
are a helpful clue to benign disease (haematoxylineeosin  200). F) Transbronchial biopsy with diffuse alveolar damage secondary
to methotrexate, showing markedly atypical pneumocytes. These worrisome but benign cells are flatter, less crowded and less
uniform than adenocarcinoma: large bizarre cells are present side-by-side with small bland cells (arrows; compare with the
monotony of adenocarcinoma shown in Fig. 7B). The acute background with fibrin is a further clue to their reactive nature
(haematoxylineeosin  400). Case shown in A, B and C is courtesy of Prof. C. Capella, Varese, Italy; case shown in D and E is
courtesy of Dr A. Dubini and Dr V. Poletti, Forli, Italy.
S18 A. Cavazza et al.meaningful in others. The field is still controversial, but the
presence of UIP at histology seems to predict a poor
survival, similar to IPF in patients with rheumatoid arthritis
and chronic HP, whereas the prognosis seems better than
IPF when UIP is related to other CVD.51,67Diagnosis of UIP against a background of
smoking-related changes
Alongside the more frequent chronic bronchitis, emphy-
sema, bronchogenic carcinoma and accumulation of finely
pigmented macrophages (respiratory bronchiolitis),68
cigarette smoking can cause fibrosis, sometimessignificant, which is part of the morphological spectrum of
smoking-related ILD (Fig. 5A and B).69e72 In some cases the
diagnosis of early UIP arising on a background of smoking-
related fibrosis can be challenging. To complicate matters,
in a recent paper in which the background parenchyma of
specimens resected for lung cancer was carefully evalu-
ated, foci of UIP were found in 3.5% of non-smokers, 15.4%
of mild smokers, 23.6% of moderate smokers and 22.4% of
heavy smokers.72 The patients for the most part had no
clinical evidence of ILD, and whether these foci of UIP
corresponded to early/subclinical IPF or were just inci-
dental findings is not known. Interestingly, acute respira-
tory failure following surgery developed only in patients
with foci of UIP.72
Table 4 Contrasting features of well-differentiated adenocarcinoma, pneumocyte hyperplasia and peribronchiolar meta-
plasia in the setting of interstitial lung disease.
Feature Adenocarcinoma Pneumocyte hyperplasia Peribronchiolar metaplasia
Clinical context A mass is frequently (but not
always) present
No mass No mass





atypia, columnar and crowded,
no cilia
Polymorphous (large atypical
cells side-by-side with small
bland cells), flattened/
cuboidal
Bland, with long cilia
Characteristics of the
histological background
Fibrosis/inflammation Acute lung injury (diffuse
alveolar damage or organizing
pneumonia)
Fibrosis/inflammation
Immunomarkers for basal cells
(p63, cytokeratin 5/6,
cytokeratin 34bE12)
Negative Negative Positive in the basal cells
surrounding the proliferation
Histology in idiopathic pulmonary fibrosis S19Another smoking-related ILD that can superficially mimic
UIP is Langerhans’ cell histiocytosis (LCH) in its chronic
phase, when the lesion becomes fibrotic and the Langer-
hans’ cells frequently disappear (Fig. 5C and D).73,74
Acute exacerbation of IPF and other fibrosing
ILD
Some patients with IPF (but also with other fibrosing ILD,
including idiopathic NSIP,75e77 chronic HP75,78,79 and ILD
related to CVD76,77,80,81) experience episodes of acute
deterioration of their illness with a high mortality rate.
When idiopathic these episodes are called acute exacer-
bation (AE).82e87 The frequency of AE in IPF is not known.
A recent retrospective review on 147 patients with IPF84
showed a 2-year incidence of AE of 9.6%; interestingly,
the incidence increased to 18% if less strict diagnostic
criteria were applied (see below). Several studies suggest
that surgical lung biopsy88 and bronchoscopy84 may occa-
sionally contribute to AE. AE can occur at any time during
the course of IPF and occasionally is the presenting mani-
festation of the disease.89 In any patient in whom acute
interstitial pneumonia/idiopathic diffuse alveolar damage
(DAD) is a consideration, the possibility of an underlying
chronic ILD should be kept in mind, particularly in older
smokers.
A recent paper82 proposed the following diagnostic
criteria for AE of IPF: 1) previous or concurrent diagnosis of
IPF; 2) unexplained worsening or development of dyspnoea
within 30 days; 3) HRCT with new bilateral alveolar infil-
trates superimposed on a background reticular or honey-
comb pattern; and 4) exclusion of alternative causes
(including no evidence of pulmonary infection by endotra-
cheal aspirate or bronchoalveolar lavage). The previously
required documentation of abnormal gas exchange, which
rendered very strict the inclusion criteria in the studies
preceding this definition, was dropped.
Biopsy is not necessary for the diagnosis in most
patients; when it is performed it generally shows DAD (or
less frequently organizing pneumonia (OP) or numerous
large fibroblastic foci)75,90 superimposed on a chronic
background of UIP. Because of the sampling problemsoutlined above, the biopsy may show just one of the two
components (DAD or UIP), and documentation of the non-
sampled component requires the correlation with the
clinico-radiological data.
An important point is that the definition of AE is clinico-
radiological, not histological. In a biopsy showing fibrotic
ILD there is sometimes an extensive acute/subacute
component (profusion of large fibroblastic foci or OP,
Fig. 6). In these cases the biopsy is generally performed for
worsening of symptoms, but the patient may or may not
reach the clinical level of impairment required for the
diagnosis of AE. As it is currently defined (and particularly
as it was defined before the paper of Collard et al.)82 AE
represents the most severe end of a spectrum. Not
surprisingly, patients with less extensive opacities at
HRCT91 and with OP rather than DAD at histology75,76,90
have less severe disease and a better outcome.Carcinoma in IPF
Patients with IPF or other fibrosing ILD are at increased risk
of developing pulmonary carcinoma. Preliminary data
suggest that squamous cell carcinoma92 and unusual vari-
ants of adenocarcinoma, including the enteric type93 (Chi-
losi M, personal communication) are more frequently seen
in IPF than the general population. The diagnosis of
malignancy in this setting is generally straightforward but
occasionally very difficult, particularly on small biopsies,
but sometimes also on surgical specimens.94,95 Some
pulmonary adenocarcinomas are so well differentiated they
are difficult to appreciate as neoplastic, in particular if the
tumour cells are few and masked by fibrosis; moreover,
some reactive conditions, particularly pneumocyte hyper-
plasia and peribronchiolar metaplasia, can be so exuberant
as to closely mimic a tumour. Some examples are shown in
Fig. 7, and the criteria for differentiating adenocarcinoma
from reactive conditions in ILD are summarized in Table 4.
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